Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...
Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...
A graphic of a purple and magenta Cas9 protein, which is a somewhat round, but uneven, ball, bound to a yellow and orange ...
Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests ...
Researchers used CRISPR to edit hematopoietic stem cells, creating B cells that produce neutralizing antibodies against HIV, ...
An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
Morning Overview on MSN
New CRISPR variant cuts tumor DNA while sparing healthy cells
Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...
New study reveals metabolic remodeling as an early event in diastolic dysfunction Restrictive cardiomyopathy (RCM) caused by ...
Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Stocktwits on MSN
Why is HOTH stock up 70% after-hours today?
HT-VA outperformed Danish drug Novo Nordisk’s blockbuster semaglutide drug in key gene expression markers tied to liver fat regulation, the company said. ・The company is now looking to advance the ...
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results